s6y Kiora Pharmaceuticals Inc EFFECT

Kiora Pharmaceuticals Inc EFFECT, filed Apr 30, 2021: Notice of Effectiveness

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 30, 2021 4:30 P.M.
Form: S-3
CIK: 0001372514
Company Name: EYEGATE PHARMACEUTICALS INC
File Number: 333-255311